Albireo Pharma
Latest round
- Series A
Last raised
- May 2008
Total raised
- $40M
Investors
- 4
About Albireo Pharma
Albireo Pharma, Inc.Albireo Pharma, Inc. is dedicated to developing treatments for rare gastrointestinal diseases. Founded in 2008, the company is headquartered in Boston, US. It emerged from a merger between Albireo Limited and Biodel Inc. in May 2016, which resulted in a shift in its operational focus.00 mn through five deals.Albireo Pharma, Inc. specializes in innovative drug development for rare gastrointestinal diseases. Their product offerings are aimed at addressing unmet medical needs and include treatments designed to improve health outcomes significantly.In 2021, Albireo Pharma, Inc.21 mn.Albireo Pharma, Inc. is strategically planning to expand its product portfolio with new therapies targeting rare gastrointestinal conditions, leveraging recent investments for research and development. The company is also exploring opportunities to enter new geographical markets, with a focus on regions such as Europe and Asia-Pacific by 2025.
Who invested in Albireo Pharma
4 investors across 1 round
See all investors in Albireo Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 7, 2008
Amount
$40M
Investors
Questions about Albireo Pharma
Who invested in Albireo Pharma?
Albireo Pharma has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Albireo Pharma raised?
Albireo Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Albireo Pharma last raise money?
Albireo Pharma's most recent round on record is a Series A, in May 2008.
What does Albireo Pharma do?
Albireo Pharma is a biotechnology company.
Where is Albireo Pharma headquartered?
Albireo Pharma is headquartered in Boston, US.
Which VCs invest in companies like Albireo Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Albireo Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Albireo Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.